ESMO20 YO for YO: highlights on metastatic renal cell carcinoma-the CheckMate-9ER trial. | ESMO Open;6(1): 100025, 2021 02. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

ESMO20 YO for YO: highlights on metastatic renal cell carcinoma-the CheckMate-9ER trial.

Kfoury, M; Oing, C.

Affiliation

Kfoury M; Department of Oncology, Gustave Roussy Cancer Center, Villejuif, France.
Oing C; Department of Oncology, Hematology and Bone Marrow Transplantation with Division of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Mildred Scheel Cancer Career Center, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: c.oing@uke.de.

ESMO Open ; 6(1): 100025, 2021 02.

Article in En | MEDLINE | ID: mdl-33399087

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Limits: Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms Limits: Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article Affiliation country: